Molecular Health

The Workbench Manager helps labs manage their bioinformatics workflows while the Clinical Annotation software offers clinical variant interpretation services.

Molecular Health has renamed its portfolio ahead of planned product launches and an early-access program for its drug safety software starting in January.

The company will use the funds to continue building out its commercial platform and to drive product adoption.

Makers of NGS cancer profiling diagnostics lauded the preliminary proposal, but pointed out areas where the coverage criteria may miss patients who might benefit from testing.

The company's results add to a growing body of evidence, including from Foundation Medicine, that suggests such techniques have clinical utility for patients. 

MolecularHealth announced that Fadi Braiteh has joined its advisory board. Braiteh is an oncologist with Comprehensive Cancer Centers of Nevada, specializing in gastro-intestinal, digestive system, and breast cancers.

Diagnostics firm Epic Sciences has appointed Greg Lucier as chairman of its board of directors.

NEW YORK (GenomeWeb) – A new cancer personalized treatment service that SAP is offering to employees living with the disease provides an opportunity for the company to put its newly minted SAP Genomic Analyzer solution — a sequence alignment and analysis software that runs on the SAP Hana infrast

GoodStart Genetics has appointed Charles Wagner, Jr., to its board of directors. Wagner is CFO and executive VP of finance and administration at Bruker Corporation. Previously, he held similar positions at Progress Software Corporatio and Millipore Corporation.

NEW YORK (GenomeWeb News) – Molecular Health today announced its US clinical laboratory has been CLIA-certified.

Pages

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.